The pandemic continues to cause unprecedented disruption across industries worldwide.
Get detailed insights regarding the impact of COVID-19 on the market.
The global medical lasers market reached a value of US$ 3.70 Billion in 2021. Looking forward, IMARC Group expects the market to reach a value of US$ 7.01 Billion by 2027, exhibiting a CAGR of 10.80% during 2022-2027. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.
Medical lasers are devices used to treat or remove tissues through precisely focused light sources. They rely on non-ionizing radiation to reduce blood loss, decrease postoperative discomfort and minimize the chances of wound infection. They aid in cancer therapy, bio-sensing, bio-imaging, drug delivery, and diagnostics of cancer cells. They also assist in cosmetic surgery to remove tattoos, scars, stretch marks, sunspots, wrinkles, birthmarks, and spider veins or hair. Apart from this, they help in tumor and cataract removal, breast surgery, plastic surgery, and other surgical procedures. As a result, they find extensive applications in hospitals, specialty clinics, and ambulatory surgical centers.
Due to the increasing adoption of minimally and non-invasive procedures to enhance clinical outcomes, there is a rise in the demand for medical lasers. This, along with the growing awareness among individuals about aesthetic procedures, such as acne prevention, body contouring, and dermal resurfacing, represents one of the key factors driving the market. Moreover, there is an increase in the utilization of medical lasers due to less pain, minimal incisions, and faster recovery across the globe. This, coupled with technological advancements in laser-assisted devices that support advance treatments in healthcare facilities with reduced risk of post-procedural complications, is propelling the growth of the market. Additionally, several initiatives undertaken by healthcare organizations to promote medical tourism are offering lucrative growth opportunities to industry investors. Besides this, key market players are extensively investing in research and development (R&D) activities to introduce a new low-level green laser for body fat reduction. Furthermore, the burgeoning healthcare industry is positively influencing the market. Other growth-inducing factors are the rising geriatric population, increasing prevalence of eye disorders, and the growing disposable incomes.
IMARC Group provides an analysis of the key trends in each sub-segment of the global medical lasers market, along with forecasts at the global, regional and country level from 2022-2027. Our report has categorized the market based on type, product type, application and end user.
Breakup by Type:
Breakup by Product Type:
Breakup by Application:
Breakup by End User:
Breakup by Region:
The competitive landscape of the industry has also been examined along with the profiles of the key players being Artivion Inc., Bausch Health Companies Inc., BIOLASE Inc., Boston Scientific Corporation, Cutera Inc., Ellex Medical Lasers (Lumibird Medical), IRIDEX Corporation, Koninklijke Philips N.V., Lumenis Ltd., Novartis AG, PhotoMedex Inc. and Syneron Medical Ltd.
|Base Year of the Analysis||2021|
|Segment Coverage||Type, Product Type, Application, End User, Region|
|Region Covered||Asia Pacific, Europe, North America, Latin America, Middle East and Africa|
|Countries Covered||United States, Canada, Germany, France, United Kingdom, Italy, Spain, Russia, China, Japan, India, South Korea, Australia, Indonesia, Brazil, Mexico|
|Companies Covered||Artivion Inc., Bausch Health Companies Inc., BIOLASE Inc., Boston Scientific Corporation, Cutera Inc., Ellex Medical Lasers (Lumibird Medical), IRIDEX Corporation, Koninklijke Philips N.V., Lumenis Ltd., Novartis AG, PhotoMedex Inc. and Syneron Medical Ltd.|
|Customization Scope||10% Free Customization|
|Report Price and Purchase Option||Single User License: US$ 2499
Five User License: US$ 3499
Corporate License: US$ 4499
|Post-Sale Analyst Support||10-12 Weeks|
|Delivery Format||PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)|
REACH OUT TO US
Call us on
( US: +1-631-791-1145 )
( UK: +44-753-713-2163 )
( India: +91 120 433 0800 )
Drop us an email at